Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bad bugs: good for cancer therapy?

Clyde M Burnham

    Drug Discovery Today
    |February 5, 2003
    PubMed
    Summary

    Researchers are using components from Listeria and Escherichia coli bacteria to stimulate the immune system. This innovative strategy aims to enhance the body's ability to fight cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Encapsulated cell technology could prevent blindness.

    Drug discovery todayยท2003
    See all related articles

    Area of Science:

    • Immunology
    • Oncology
    • Microbiology

    Background:

    • Cancer immunotherapy harnesses the immune system to combat malignancies.
    • Novel strategies are needed to improve treatment efficacy and overcome resistance.
    • Bacterial components can modulate immune responses.

    Purpose of the Study:

    • To investigate the potential of bacterial components from Listeria and Escherichia coli as cancer immunotherapeutics.
    • To evaluate the ability of these components to prime the immune system against cancer cells.

    Main Methods:

    • Utilizing specific components derived from Listeria and Escherichia coli.
    • Administering these components to prime the host immune system.
    • Assessing the resulting immune activation and anti-cancer effects.

    Main Results:

    • Demonstrated successful priming of the immune system using bacterial components.
    • Observed enhanced immune responses with potential anti-cancer activity.

    Conclusions:

    • Components of Listeria and Escherichia coli represent a promising novel approach for cancer immunotherapy.
    • Further research is warranted to optimize this strategy for clinical application.

    Related Experiment Videos